Terms: = Liver cancer AND RPL22, EAP, 6146 AND Treatment
17 results:
1. Cost analysis of robotic versus open hepatectomy: Is the robotic platform more expensive?
Shapera E; Sucandy I; Syblis C; Crespo K; Ja'Karri T; Ross S; Rosemurgy A
J Robot Surg; 2022 Dec; 16(6):1409-1417. PubMed ID: 35152343
[TBL] [Abstract] [Full Text] [Related]
2. Is dual-phase C-arm CBCT sufficiently accurate for the diagnosis of colorectal cancer liver metastasis during liver intra-arterial treatment?
Pellerin O; Pereira H; Van Ngoc Ty C; Moussa N; Del Giudice C; Pernot S; Déan C; Chatellier G; Sapoval M
Eur Radiol; 2019 Oct; 29(10):5253-5263. PubMed ID: 30937583
[TBL] [Abstract] [Full Text] [Related]
3. Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program.
Bracarda S; Galli L; Maruzzo M; Lo Re G; Buti S; Favaretto A; Di Costanzo F; Sacco C; Merlano M; Mucciarini C; Zafarana E; Romito S; Maestri A; Giorgio CG; Ionta MT; Turci D; De Giorgi U; Procopio G; Cortesi E; Giannarelli D; Porta C
Future Oncol; 2018 Jun; 14(14):1347-1354. PubMed ID: 29774766
[TBL] [Abstract] [Full Text] [Related]
4. Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program.
Sartor O; Vogelzang NJ; Sweeney C; Fernandez DC; Almeida F; Iagaru A; Brown A; Smith MR; Agrawal M; Dicker AP; Garcia JA; Lutzky J; Wong YN; Petrenciuc O; Gratt J; Shore ND; Morris MJ;
Oncologist; 2018 Feb; 23(2):193-202. PubMed ID: 29183960
[TBL] [Abstract] [Full Text] [Related]
5. Sorafenib-Regorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: A Single-Institute Experience.
Ueshima K; Nishida N; Kudo M
Dig Dis; 2017; 35(6):611-617. PubMed ID: 29040994
[TBL] [Abstract] [Full Text] [Related]
6. liver Metastasis and treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC.
Tumeh PC; Hellmann MD; Hamid O; Tsai KK; Loo KL; Gubens MA; Rosenblum M; Harview CL; Taube JM; Handley N; Khurana N; Nosrati A; Krummel MF; Tucker A; Sosa EV; Sanchez PJ; Banayan N; Osorio JC; Nguyen-Kim DL; Chang J; Shintaku IP; Boasberg PD; Taylor EJ; Munster PN; Algazi AP; Chmielowski B; Dummer R; Grogan TR; Elashoff D; Hwang J; Goldinger SM; Garon EB; Pierce RH; Daud A
Cancer Immunol Res; 2017 May; 5(5):417-424. PubMed ID: 28411193
[TBL] [Abstract] [Full Text] [Related]
7. Delayed-Phase Cone-Beam CT Improves Detectability of Intrahepatic Cholangiocarcinoma During Conventional Transarterial Chemoembolization.
Schernthaner RE; Lin M; Duran R; Chapiro J; Wang Z; Geschwind JF
Cardiovasc Intervent Radiol; 2015 Aug; 38(4):929-36. PubMed ID: 25476872
[TBL] [Abstract] [Full Text] [Related]
8. Gefitinib (ZD1839): therapy in selected patients with non-small cell lung cancer (NSCLC)?
Dongiovanni D; Daniele L; Barone C; Dongiovanni V; Fissore C; Sapino A; Macrì L; Bussolati G; Buffoni L; Gaspari F; Grillo R; Birocco N; Addeo A; Ciuffreda L; Schena M
Lung Cancer; 2008 Jul; 61(1):73-81. PubMed ID: 18243402
[TBL] [Abstract] [Full Text] [Related]
9. Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer.
Hartmann JT; Quietzsch D; Daikeler T; Kollmannsberger C; Mayer F; Kanz L; Bokemeyer C
Anticancer Drugs; 1999 Sep; 10(8):729-33. PubMed ID: 10573205
[TBL] [Abstract] [Full Text] [Related]
10. [Successful treatment of two patients with advanced gastric cancer by neoadjuvant chemotherapy with eap regimen].
Matsumura T; Ohnoshi T; Ueoka H; Kiura K; Tabata M; Genba K; Chikamori M; Ikubo S; Matsuo K; Kimura I
Gan To Kagaku Ryoho; 1994 Feb; 21(2):261-4. PubMed ID: 8311499
[TBL] [Abstract] [Full Text] [Related]
11. Combination therapy consisting of arterial infusion chemotherapy (EPF, eap) and transcatheter arterial embolization (TAE).
Yodono H; Takekawa SD; Tarusawa K; Ikami I; Kanehira J; Saito Y; Takahashi S; Sasaki T; Nishi N; Kimura T
Cancer Chemother Pharmacol; 1994; 33 Suppl():S79-83. PubMed ID: 8137489
[TBL] [Abstract] [Full Text] [Related]
12. [Four cases of advanced adenocarcinoma showing marked response to eap (etoposide, ADM, CDDP) treatment].
Iba T; Yagi Y; Kidokoro A; Fukunaga M; Fukunaga T; Mishima S
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2383-5. PubMed ID: 8259856
[TBL] [Abstract] [Full Text] [Related]
13. [Evaluation of the combination of chemotherapy with etoposide, adriamycin and cisplatin (eap) in advanced or recurrent gastric cancer].
Terata N; Sano H; Ishibashi H; Tani T; Hanasawa K; Endo Y; Kurumi Y; Shibata J; Kodama M; Tsuji K
Gan To Kagaku Ryoho; 1993 Apr; 20(5):611-6. PubMed ID: 8470918
[TBL] [Abstract] [Full Text] [Related]
14. Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
Ajani JA; Roth JA; Ryan MB; Putnam JB; Pazdur R; Levin B; Gutterman JU; McMurtrey M
J Clin Oncol; 1993 Jan; 11(1):22-8. PubMed ID: 8418237
[TBL] [Abstract] [Full Text] [Related]
15. [Combination therapy with 5-FU, etoposide and CDDP (FEP regimen) in advanced primary and recurrent gastric cancer].
Namatame K; Sasaki E; Koh Y; Shimada K; Nakamura T; Hirose T; Ookubo M; Nakayoshi A
Gan To Kagaku Ryoho; 1992 May; 19(5):625-30. PubMed ID: 1580637
[TBL] [Abstract] [Full Text] [Related]
16. Arterial infusion chemotherapy for advanced hepatocellular carcinoma using EPF and eap therapies.
Yodono H; Sasaki T; Tarusawa K; Midorikawa H; Saito Y; Takekawa SD
Cancer Chemother Pharmacol; 1992; 31 Suppl():S89-92. PubMed ID: 1333915
[TBL] [Abstract] [Full Text] [Related]
17. Management of esophageal, gastric, pancreatic, and hepatobiliary neoplasms.
Bleiberg H
Curr Opin Oncol; 1991 Aug; 3(4):737-44. PubMed ID: 1657205
[TBL] [Abstract] [Full Text] [Related]
